Showing results (171-180 of 861) with videos related to
Sort By:
Pageof 87
Neuroimage|September 16, 2008
Structural connectivity influences brain activation during PVSAT in Multiple SclerosisLaura Bonzano, Matteo Pardini, Gian Luigi Mancardi, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|June 10, 2010
Optimal design and analysis of phase I/II clinical trials in multiple sclerosis with gadolinium-enhanced lesions as the endpointBrian C Healy, David Ikle, Eric A Macklin, et al.Therapeutic Advances in Neurological Disorders|March 6, 2019
Evolution of clinical trials in multiple sclerosisYinan Zhang, Amber Salter, Erik Wallström, et al.Optometry and Vision Science : Official Publication of the American Academy of Optometry|December 14, 2021
Accuracy and Repeatability of Internet-ordered Spectacle LensesAdam Gordon, Michael D Twa, Gary Cutter, et al.Nutrients|December 28, 2021
Diet Quality Assessment in Wheelchair Users with Multiple SclerosisStephanie L Silveira, Brenda Jeng, Gary Cutter, et al.Neurology|August 31, 2016
MRI in the evaluation of pediatric multiple sclerosisBrenda Banwell, Douglas L Arnold, Jan-Mendelt Tillema, et al.Annals of Clinical and Translational Neurology|July 12, 2017
Dysregulation of 14-3-3 proteins in neurodegenerative diseases with Lewy body or Alzheimer pathologyMichael B McFerrin, Xiaofei Chi, Gary Cutter, et al.Archives of Physical Medicine and Rehabilitation|January 17, 2023
Diet, Physical Activity, and Stress Among Wheelchair Users With Multiple Sclerosis: Examining Individual and Co-Occurring Behavioral Risk FactorsStephanie L Silveira, Brenda Jeng, Gary Cutter, et al.Journal of Clinical Neurology (Seoul, Korea)|July 10, 2019
Examining the Impact of Refractory Myasthenia Gravis on Healthcare Resource Utilization in the United States: Analysis of a Myasthenia Gravis Foundation of America Patient Registry SampleHaichang Xin, Linda A Harris, Inmaculada B Aban, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2014
Pathologic complete response as a potential surrogate for the clinical outcome in patients with breast cancer after neoadjuvant therapy: a meta-regression of 29 randomized prospective studiesAlfredo Berruti, Vito Amoroso, Fabio Gallo, et al.Pageof 87